Home › NCT06935695
Surveillance Versus Bronchoscopy After Airway Stenting
Recruiting
Surveillance Versus Prn bronChOscoPy aftEr aIrway stenTing (SCOPE-IT)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria: * All adult patients that undergo central airway (trachea, main stem bronchi and bronchus intermedius) stenting. Exclusion Criteria: * Inability to obtain informed consent due to cognitive, neurologic or psychiatric impairment. * Lobar or segmental stents alone * Terminally ill patients considered too sick to undergo a follow-up surveillance bronchoscopy * Stent insertion as a trial for excessive central airway collapse (as the duration of these stents is only 1-2 weeks) * Patients with a tracheostomy (as these patients can undergo frequent in-line suctioning that can affect the outcomes being assessed)
About the study
Randomized, pilot study that evaluates surveillance bronchoscopy versus no surveillance for patients that undergo tracheobronchial stenting
What is being tested
- Bronchoscopy (device)
Sponsor: Icahn School of Medicine at Mount Sinai · Participants: 50 · Started: Jan 1, 2025
Contact the study team
- Axel Duval, MD · Phone: (212) 824-8546
Official record on ClinicalTrials.gov — NCT06935695
Locations in the U.S.
| New York | The Mount Sinai Health System, New York |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.